These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1227752)

  • 1. [Controlled clinical study of large doses of etaphenone in coronary insufficiency].
    Del Guerico R
    Clin Ter; 1975 Aug; 74(4):337-63. PubMed ID: 1227752
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experience with the use of high intravenous doses of a coronary-active drug in the treatment of acute and chronic coronary insufficiency].
    Cinelli P; Grazzini M
    Minerva Cardioangiol; 1969 May; 17(5):317-23. PubMed ID: 5814987
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical management of coronary insufficiency using Etafenon and its results (report from 3 Berlin hospitals)].
    Pietschmann G
    Dtsch Med J; 1972 Dec; 23(12):713-5. PubMed ID: 4659006
    [No Abstract]   [Full Text] [Related]  

  • 4. [General aspects of a project of a controlled clinical experimentation with coronary-active drug, evaluated on the base of the onset of remission of signs and symptoms].
    Rocchi P; Cavrini P
    Boll Chim Farm; 1972 Sep; 111(9):579-82. PubMed ID: 4565804
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of ethaphenone for the treatment of ischemic heart disease].
    Savenkov PM; Shcherbatkin DD; Grudtsyn GV; Katashchuk GI; Tarnuev VA
    Kardiologiia; 1978 Mar; 18(3):43-7. PubMed ID: 347137
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical experience with oxyphedrine. Action on the heart and coronary therapy (author's transl)].
    Castillo Bernal A; Sáez de Santa María IE
    Folia Clin Int (Barc); 1974; 24(7):573-8. PubMed ID: 4408919
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical evaluation of Ildamen].
    Krzemińska-Pakuła M; Musiał WJ
    Pol Tyg Lek; 1979 Dec; 34(52):2053-5. PubMed ID: 396524
    [No Abstract]   [Full Text] [Related]  

  • 8. [Oxyphedrine in the treatment of coronary insufficiency: clinical evaluation].
    França HH; Martins L
    Arq Bras Cardiol; 1971 Apr; 24(2):23-30. PubMed ID: 5162299
    [No Abstract]   [Full Text] [Related]  

  • 9. [Controlled clinical study of a coronary active drug (etaphenone chlorhydrate) for parenteral administration].
    Del Giallo P; Valiensi M
    Minerva Cardioangiol; 1972 Nov; 20(11):642-57. PubMed ID: 4566131
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical experience with oxyphedrine in the treatment of ischemic cardiopathy].
    Almeida SP
    Rev Bras Med; 1971 Dec; 28(12):644-52. PubMed ID: 5145755
    [No Abstract]   [Full Text] [Related]  

  • 11. [Glycoside and coronary therapy with Ildamen-Novodigal].
    Moosdorf S; Reincke J
    Ther Ggw; 1974 Nov; 113(11):1921-39. PubMed ID: 4462219
    [No Abstract]   [Full Text] [Related]  

  • 12. [Value of oxyfedrine in the treatment of coronary disease. Apropos of 100 cases].
    Hiltenbrandt C; Gerard A; Maecker P; Desruelles J
    Lille Med; 1972 Oct; 17(9):1288-93. PubMed ID: 4657642
    [No Abstract]   [Full Text] [Related]  

  • 13. Oxyfedrine and cardiac inotropism in coronary artery disease.
    Krishnaswami S; Sathyamurthy I; Mao R; Padmakumar P
    Indian Heart J; 1984; 36(3):161-5. PubMed ID: 6490047
    [No Abstract]   [Full Text] [Related]  

  • 14. [Anti-arrhythmic effects of propafenone in coronary patients with ventricular arrhythmias].
    Fiol M; Palma JL; Bayés de Luna A; Aza V; Sadurní J
    Rev Esp Cardiol; 1984; 37(3):196-200. PubMed ID: 6505351
    [No Abstract]   [Full Text] [Related]  

  • 15. [Positive inotropic effect of coronary-active drug: oxyfedrine].
    Conti G; Moreschini G; Pelosi M
    Minerva Cardioangiol; 1980 Sep; 28(9):645-7. PubMed ID: 7465070
    [No Abstract]   [Full Text] [Related]  

  • 16. Demand method evaluation of analgesics.
    Sechzer PH
    Curr Ther Res Clin Exp; 1976 Mar; 19(3):343-9. PubMed ID: 817864
    [No Abstract]   [Full Text] [Related]  

  • 17. [Action of oxyphedrine on ventricular dynamics in ischemic cardiopathy].
    Barbosa J; Lopes AS; Lopes JS; Vergara M; Benchimol AB
    Arq Bras Cardiol; 1972 Jun; 25(3):231-9. PubMed ID: 5079398
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical comparative study of perexiline maleate and prenylamine in the treatment of chronic coronary insufficiency].
    Labriola E
    Clin Ter; 1975 Feb; 72(4):337-51. PubMed ID: 1222513
    [No Abstract]   [Full Text] [Related]  

  • 19. Oxyfedrine on left ventricular performance.
    Manchanda SC; Reddy KS; Kasturi TE
    Indian Heart J; 1980; 32(6):339-41. PubMed ID: 7228080
    [No Abstract]   [Full Text] [Related]  

  • 20. [Value of propafenon in the control of ventricular extrasystolic arrhythmia. Clinical, electrocardiographic and laboratory evaluation in prolonged use].
    Giannini SD; Zillioto EE; Campanari JC; Formicola A
    Arq Bras Cardiol; 1980 Dec; 35(6):525-8. PubMed ID: 6167246
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.